{"product_id":"ibuprofen-lysine-injection-20-mg-per-2-ml-10-mg-ml-single-dose-3-vials","title":"Ibuprofen Lysine Injection 20 mg Per 2 mL (10 mg\/mL) Single-Dose (3 Vials) (RX)","description":"Ibuprofen Lysine Injection, marketed under the brand name NeoProfen, is an intravenous (IV) medication used to treat patent ductus arteriosus (PDA), a heart condition in premature infants. As a nonsteroidal anti-inflammatory drug (NSAID), it is administered in a hospital setting under the careful supervision of a healthcare professional.\n\u003cp\u003eIbuprofen Lysine Injection 20 mg per 2 mL (10 mg\/mL) by XGen Pharmaceuticals is a sterile, preservative-free, single-dose injectable solution specifically engineered for professional hospital use. This product is designed to deliver fast-acting, reliable relief for clinical conditions that require intravenous administration of ibuprofen, providing both anti-inflammatory and antipyretic benefits. Each package contains 3 single-dose vials, supporting precise dosing and safety.\u003c\/p\u003e\n\u003ch3\u003eWhat It Is Used For\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTreatment of clinically significant patent ductus arteriosus (PDA) in premature infants\u003c\/strong\u003e (most common use)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of pain and inflammation\u003c\/strong\u003e when oral or enteral delivery is not feasible\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduction of fever\u003c\/strong\u003e in hospitalized patients when IV therapy is required\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eIbuprofen Lysine Injection is most commonly utilized in the neonatal intensive care setting for targeted closure of patent ductus arteriosus in preterm infants.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eDetails \u0026amp; Features\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 20 mg per 2 mL vial (10 mg\/mL concentration)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Ready-to-use sterile injectable solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackage:\u003c\/strong\u003e 3 single-dose vials per box for accurate and secure dosing\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreservative-Free:\u003c\/strong\u003e Reduced risk of additive-related reactions\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFast-Acting:\u003c\/strong\u003e Rapid onset for critical care and NICU protocols\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliable Manufacturer:\u003c\/strong\u003e Produced by XGen Pharmaceuticals, a leader in quality and innovation\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFor Hospital and Licensed Clinical Use Only\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eFor intravenous (IV) use only.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Inspect vial for particulate matter or discoloration. Use aseptic technique for both preparation and administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Infuse as a slow IV injection over the time specified by your healthcare institution or dosing protocol—commonly up to 15 minutes in neonatal use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle Dose Only:\u003c\/strong\u003e Discard any unused portion of the vial after opening.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eTo be administered exclusively by trained healthcare professionals in a hospital setting.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eDosage\u003c\/h3\u003e\n\u003ch4\u003eFor the Treatment of PDA in Preterm Infants:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInitial Dose:\u003c\/strong\u003e 10 mg\/kg as an IV infusion\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecond \u0026amp; Third Doses:\u003c\/strong\u003e 5 mg\/kg each, at 24 and 48 hours after the initial dose (if clinically indicated)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eFor Other Indications (as determined by physician):\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eDosage and frequency must be determined by a healthcare provider based on patient-specific factors, indication, age, and body weight.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eConsult medical protocols and\/or product insert for detailed dosing guidelines.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eAllergies\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eContraindicated In:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePatients with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the injection\u003c\/li\u003e\n\u003cli\u003ePatients with a history of asthma, urticaria, or allergic-type reactions after NSAID use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDrug Interactions\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther NSAIDs or Aspirin:\u003c\/strong\u003e Increased risk for adverse effects\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnticoagulants (e.g., Warfarin):\u003c\/strong\u003e Heightened risk of bleeding\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCorticosteroids:\u003c\/strong\u003e Elevated risk of GI ulceration or bleeding\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eACE Inhibitors, ARBs, Diuretics:\u003c\/strong\u003e May augment kidney impairment\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAminoglycoside Antibiotics:\u003c\/strong\u003e Possible elevated nephrotoxicity in neonates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eComprehensive medication review is needed before administration.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eSide Effects or Warnings\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMild changes in lab values (creatinine, platelet count)\u003c\/li\u003e\n\u003cli\u003eLocal irritation at injection site\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eKidney dysfunction (especially in premature infants)\u003c\/li\u003e\n\u003cli\u003eBleeding tendencies, GI hemorrhage\u003c\/li\u003e\n\u003cli\u003eHypotension or hypertension\u003c\/li\u003e\n\u003cli\u003eInfection risk due to altered immune response\u003c\/li\u003e\n\u003cli\u003eElectrolyte imbalances (hyponatremia, hyperkalemia)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eOnly for use under close hospital supervision and monitoring\u003c\/li\u003e\n\u003cli\u003eNot for use in patients with active bleeding, significant renal impairment, or necrotizing enterocolitis\u003c\/li\u003e\n\u003cli\u003eRisk of bronchopulmonary dysplasia in neonates\u003c\/li\u003e\n\u003cli\u003eNot indicated for routine pain or fever management in adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eIf any severe side effects, signs of allergic reaction, or unusual symptoms occur, contact a physician or initiate emergency protocols immediately.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eChoose Ibuprofen Lysine Injection 20 mg per 2 mL (10 mg\/mL) by XGen Pharmaceuticals — Trusted, Targeted Hospital Therapy for PDA Closure and IV NSAID Needs.\u003c\/span\u003e\u003c\/p\u003e","brand":"XGen Pharmaceuticals","offers":[{"title":"Default Title","offer_id":52493369508208,"sku":"39822-1030-02","price":1725.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ibuprofen-Lysine-Injection-20-mg.jpg?v=1755709178","url":"https:\/\/www.mountainside-medical.com\/products\/ibuprofen-lysine-injection-20-mg-per-2-ml-10-mg-ml-single-dose-3-vials","provider":"Mountainside Medical","version":"1.0","type":"link"}